- Home
- CEAD vs BCLI Comparison
CEAD vs BCLI Comparison
Compare CEAD & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEAD
- BCLI
- Stock Information
- Founded
- CEAD 2009
- BCLI 2000
- Country
- CEAD United States
- BCLI United States
- Employees
- CEAD N/A
- BCLI N/A
- Industry
- CEAD Industrial Machinery/Components
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CEAD Industrials
- BCLI Health Care
- Exchange
- CEAD Nasdaq
- BCLI Nasdaq
- Market Cap
- CEAD 5.6M
- BCLI 6.4M
- IPO Year
- CEAD N/A
- BCLI N/A
- Fundamental
- Price
- CEAD $6.00
- BCLI $1.25
- Analyst Decision
- CEAD
- BCLI Strong Buy
- Analyst Count
- CEAD 0
- BCLI 1
- Target Price
- CEAD N/A
- BCLI $30.00
- AVG Volume (30 Days)
- CEAD 10.5K
- BCLI 120.5K
- Earning Date
- CEAD 11-14-2024
- BCLI 11-14-2024
- Dividend Yield
- CEAD N/A
- BCLI N/A
- EPS Growth
- CEAD N/A
- BCLI N/A
- EPS
- CEAD N/A
- BCLI N/A
- Revenue
- CEAD $2,637,116.00
- BCLI N/A
- Revenue This Year
- CEAD N/A
- BCLI N/A
- Revenue Next Year
- CEAD N/A
- BCLI N/A
- P/E Ratio
- CEAD N/A
- BCLI N/A
- Revenue Growth
- CEAD N/A
- BCLI N/A
- 52 Week Low
- CEAD $5.22
- BCLI $1.05
- 52 Week High
- CEAD $11.04
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- CEAD 30.79
- BCLI 27.21
- Support Level
- CEAD $5.60
- BCLI $1.05
- Resistance Level
- CEAD $6.61
- BCLI $1.30
- Average True Range (ATR)
- CEAD 0.31
- BCLI 0.18
- MACD
- CEAD -0.09
- BCLI 0.04
- Stochastic Oscillator
- CEAD 26.44
- BCLI 24.69
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.